Is IM Cannabis Corp (IMCC) Stock About to Get Hot Friday?

Overall market sentiment has been high on IM Cannabis Corp (IMCC) stock lately. IMCC receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

IM Cannabis Corp has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on IMCC!

See Full IMCC Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With IMCC Stock Today?

IM Cannabis Corp (IMCC) stock is trading at $0.40 as of 3:41 PM on Friday, Sep 30, a loss of $0.00, or -0.15% from the previous closing price of $0.40. Volume today is below average. So far 56,061 shares have traded compared to average volume of 344,472 shares. The stock has traded between $0.40 and $0.42 so far today. To see InvestorsObserver's Sentiment Score for IM Cannabis Corp click here.

More About IM Cannabis Corp

IM Cannabis Corp is a Canada-based international medical cannabis company. It offers government-licensed cannabis products, from generic to GMP-certified and pharmaceutical-grade, for both wholesale and retail clients. The majority of its revenues are generated from sales of medical cannabis products to customers in Israel and recreational cannabis in Canada. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Click Here to get the full Stock Report for IM Cannabis Corp stock.